Vermialdazol

Form for Providing Information on Developed Biologically Active Supplements

Product name (generic/trade name):
Vermialdazol NIIVS

Composition of the product (active substance):
Grape juice, tansy extract, grape vinegar, chamomile extract, drinking water, emulsifiers, and auxiliary substances.

Purpose of use:
The preparation is intended for the prevention and treatment of helminthiasis (parasitic diseases caused by various types of worms).

Properties

Anthelmintic properties.

High level of bioavailability.

The emulsion form ensures convenient administration and ease of use.

Indications for Use / Field of Application

Prevention and treatment of various helminth infections in adults and children.

Directions for Use and Dosage

Adults: 10 ml once daily before meals.

Children: 5 ml once daily, recommended to be mixed with juice or water.

Course duration: 5–7 days depending on the clinical condition.

Dosage Form

Emulsion in bottles of 50 ml and 100 ml.

Author(s) of the Development

Kh.M. Komilov, A.A. Ashurov, A. Qo‘chqorov

Intellectual Property Protection (Copyright Certificates and Patents)

Ts 0189793871-003:2021 and T018979371-003:2021, approved on 24.06.2021.

Advantages of the Development Compared to Analogues
Effectiveness

Vermialdazol NIIVS demonstrated higher effectiveness compared to its analogues, ensuring a 90% reduction in parasite levels by the third day of use, whereas traditional medications show similar results only by the seventh day. These data are confirmed by clinical trial results.

Safety

The preparation is safe for use in children, pregnant, and breastfeeding women, as no serious adverse effects were recorded during clinical studies. Vermialdazol can be used for long periods without the risk of developing toxic effects, which distinguishes it from many similar drugs.

Ease of Use in Medical Practice

The emulsion form of the preparation ensures convenient dosing and administration, which is especially important for children who have difficulty swallowing tablets. The emulsion has a pleasant taste, which helps improve adherence to the treatment regimen.

Affordability

Vermialdazol NIIVS is available at a lower price, approximately 20% cheaper than many analogues. This makes it accessible to a wider range of consumers and increases treatment availability for patients with different financial conditions.

Availability on the Market

The preparation is widely available in pharmacy networks and can also be ordered online. Unlike some analogues that may be in limited supply, Vermialdazol NIIVS maintains stable availability in the market and is present in most pharmacies.